A Longitudinal Seroconversion Panel Shows Anti-SARS-CoV-2 Antibody Levels up to 6.5 Months After Vaccination with mRNA-1273 (Moderna)
BACKGROUND Vaccines have emerged as a crucial tool in combatting the COVID-19 pandemic particularly those based on SARS-CoV-2 S-protein mRNA. A crucial aspect of vaccine efficacy is the duration of antibody responses. In this study, a seroconversion panel was created to assess antibody responses to...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-10-01
|
| Series: | Plasmatology |
| Online Access: | https://doi.org/10.1177/26348535221129232 |